Advances in the Diagnosis and Treatment of a Driving Target: RET Rearrangements in non-Small-Cell Lung Cancer (NSCLC) Especially in China

In the era of precision medicine, with the deepening of the research on malignant tumor driving genes, clinical oncology has fully entered the era of targeted therapy. For non-small-cell lung cancer (NSCLC), the development of targeted drugs targeting driver genes, such as epidermal growth factor re...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tao, Yang, Wen-Yu, Liu, Ting-Ting, Li, Yao, Liu, Lu, Zheng, Xuan, Zhao, Lei, Zhang, Fan, Hu, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Screening, Diagnosis, and Treatment of Lung Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837270/
https://www.ncbi.nlm.nih.gov/pubmed/36628459
http://dx.doi.org/10.1177/15330338221148802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837270/
https://www.ncbi.nlm.nih.gov/pubmed/36628459
http://dx.doi.org/10.1177/15330338221148802

Ejemplares similares